Why is Zim Laboratories falling/rising?

As of 10-Jul, Zim Laboratories Ltd is currently priced at 115.40, reflecting a slight increase of 0.2 (0.17%). The stock has shown a positive trend, gaining 7.2% over the past week and outperforming its sector by 0.74%. It has been on a consecutive gain streak for the last five days, and it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, despite an annual return of 8.41%, the company has faced challenges with a significant profit decline of 29.5% over the past year, and it has reported negative results for the last four consecutive quarters. The stock is currently trading at a discount compared to its peers, which may attract some investors, but the long-term growth prospects remain concerning due to a modest net sales growth rate of 6.41% over the last five years.
In the broader market context, Zim Laboratories has outperformed the Sensex, which has seen a slight decline of 0.06% over the past week, while Zim's performance stands at a robust 7.2%. This indicates that investor sentiment towards Zim Laboratories is relatively positive compared to the overall market. However, the lack of domestic mutual fund investment, which stands at 0%, suggests that institutional investors may be wary of the company's long-term prospects, potentially impacting future stock performance.